Recent Updates
Recently added Catalysts
TMO Positive Sentiment

Thermo Fisher Scientific Authorizes $5 Billion of Share Repurchases

Thursday, November 5, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Thermo Fisher Scientific has authorized a $5 billion share repurchase program. This new authorization replaces the previous one, which had $1 billion remaining. The program allows for repurchases in the open market or through negotiated transactions and has no expiration date.

Market Sentiment Analysis

POSITIVE FACTORS

  • Authorization of $5 billion share repurchase
  • No expiration date for the repurchase
  • Replaces existing authorization effectively

Full Press Release Details

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized the repurchase of up to an aggregate of $5 billion of shares of its common stock in the open market or in negotiated transactions. The authorization has no expiration date. This replaces the company’s existing repurchase authorization, of which $1 billion was remaining. About Thermo Fisher Scientific Thermo Fisher Scientific

Frequently Asked Questions

What is the amount authorized for share repurchase?

$5 billion has been authorized for share repurchase.

Is there an expiration date for the repurchase?

No, the authorization has no expiration date.

What replaces the new share repurchase authorization?

It replaces the previous authorization with $1 billion remaining.

How will the shares be repurchased?

Shares will be repurchased in the open market or through negotiated transactions.

ShareAdd on Google
Tags: TMO Thermo Fisher share repurchase buyback program Waltham
Last updated: Nov 5, 2026

Biotech snapshot

Cash runway
$6061M liquidity · $0M/mo burn
Low dilution risk